Target intelligence / Profile preview

Antimicrobial peptide-mediated bacterial membrane disruption

Molecular classification
Other (peptide-based mechanism)
01

Overview

The entry "Bacterial membrane disruption by antimicrobial peptides tdAMP-1/tdAMP-2 against Gram-negative bacteria including Salmonella Typhi/E coli" does not refer to a single canonical molecular target such as a receptor, enzyme, or transporter. Instead, it describes the general mechanism of action for a class of molecules—antimicrobial peptides (AMPs), specifically tomato-derived AMPs named tdAMP-1 and tdAMP-2. These peptides exert their antibacterial effects primarily by disrupting the integrity of the bacterial cell membrane, leading to leakage of cellular contents and rapid bacterial death[6]. This is considered a broad biophysical effect rather than interaction with a discrete molecular target. Some AMPs can also enter cells and interfere with intracellular processes like protein synthesis or nucleic acid function; however, for most Trp/Arg-rich AMPs—including those similar in structure to tdAMPs—the primary mode is membrane permeabilization[1][3]. There is no evidence that these particular AMPs act on specific receptors or enzymes within bacteria. Because this entry refers to an action/mechanism rather than an individual molecule/receptor/protein that could be targeted by drugs in the conventional sense, it should be marked as incorrect for structured drug-target databases. The correct approach would be to list each AMP individually if needed ("Tomato-derived antimicrobial peptide 1", "Tomato-derived antimicrobial peptide 2") but not "bacterial membrane disruption" itself as a target. These tdAMPs have demonstrated potent antimicrobial properties by effectively disrupting bacterial membranes. The efficacy of tdAMP‑2 is shown... [6] Tryptophan‑ and arginine‑rich AMPs interact strongly with negatively charged components in Gram‑negative outer membranes; their main function is direct permeabilization/disruption rather than binding specific proteins.[1][3] In summary: this entry describes an antibacterial mechanism mediated by certain peptides—not a canonical druggable biological target—and should not be treated as such in structured data systems.

Other names
Antimicrobial peptides (AMPs)tdAMP-1tdAMP-2tomato-derived antimicrobial peptides
02

Mechanism of action

Disruption of bacterial cell membranes leading to cell death[6]

03

Biological functions

Bacterial cell membrane disruptionInhibition of protein synthesis
04

Disease associations

Infection (specifically Gram-negative bacterial infections such as Salmonella Typhi and Escherichia coli)
05

Safety considerations

Potential cytotoxicity to host cells at high concentrations or with non-selective AMPs[1][3]
06

Interacting drugs

None (tdAMPs themselves are investigational agents/peptides, not drugs targeting a specific molecular target)
07

Biomarkers

None known

Beyond the preview

Go deeper on Antimicrobial peptide-mediated bacterial membrane disruption.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antimicrobial peptide-mediated bacterial membrane disruption.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call